Evaluation of Adjuvant! Online to predict the effect of optimal endocrine therapy
 

http://www.abstract.asco.org/AbstView_65_31886.html

"Conclusions: AOL appears to underestimate the effectiveness of adjuvant endocrine therapy alone for premenopausal women with endocrine responsive breast cancer, thus overestimating the added benefit - if any - from chemotherapy for this patient population. Prospective clinical trials addressing the question are warranted."

Hopeful